Dublin, 07 Oct 2021 (GLOBE NEWSWIRE) – The report “Global DNA & RNA Banking Services Market 2021-2027” has been added to ResearchAndMarkets.com offer.
The global DNA and RNA banking market size is projected to reach USD 8.83 billion by 2027 and is expected to grow at a CAGR of 5.46%
Biospecimens such as DNA and RNA are essential for the discovery of biomarkers, paving the way for the expansion of personalized medicine. In addition, advances in translational and clinical research through the introduction of advanced and standardized solitary confinement methodologies reduce handling time. The development of automated solutions and the transformation of biobanks into fully automated biobanks potentially accelerates market growth.
An increase in the number of people signed up for personalized medicine initiatives generates revenue for DNA and RNA banking services. In July 2019, Partners HealthCare, United States, enrolled more than 100,000 people in its precision medicine biobank which has supported clinicians and researchers at Brigham and Women’s Hospital, United States, and other partners. Such an initiative has helped to examine the impact of several factors on disease and health.
The distribution network is continually becoming complex, as pharmaceutical companies face new challenges related to sustainability initiatives, regulatory compliance and cost pressures from competing priorities.
Efforts by major players to invest in cold chain storage and expansion of distribution capacity in various geographies have increased the capacity to handle large quantities of complex cold chain biologics.
Key companies such as EasyDNA, DNA Genotek, 23andMe, GoodCell, ProteoGenex. and US Biolab have adopted several strategic alliances to strengthen their presence in the market.
Highlights of DNA and RNA Banking Market Report
By type of service, storage services accounted for the largest share of revenue in 2020 due to the presence of many key vendors in the market space. The advent of automated sample storage systems and automated liquid handlers to handle large volume of samples and reduce the time required to process, store and dispense samples further drives the segment
On the basis of sample type, the blood segment dominated the market in 2020 due to fast and rapid blood collection procedures, minimal risk of contamination and visibility of blood samples.
In terms of application, the drug discovery and clinical research segment held the largest share in 2020. Biobank services are used to accelerate the discovery of new therapies and provide resources for future investigations to better understand the effects of environmental, genetic and lifestyle factors on human health, morbidity and mortality. This factor led to the maximum segment revenue share
On the basis of end use, the hospital and diagnostic center segment is expected to experience the fastest growth throughout the forecast period due to efforts by government agencies and biobanks to expand accessibility DNA and RNA Samples in Hospitals and Diagnostic Centers for COVID-19 Diagnosis
North America accounted for the largest share of revenue in 2020. One of the main factors in positively accelerating market growth is the launch of national precision medicine initiatives, such as the ‘All of Us’ biobank. ” in the USA.
Main topics covered:
Chapter 1 Methodology and Scope of DNA and RNA Banking Services
Chapter 2 Executive Summary of DNA and RNA Banking Services
Chapter 3 Variables, Trends and Scope of DNA and RNA Banking Services Market
3.1 Market trends and outlook
3.2 Market Lineage Outlook
3.2.1 Parents’ Market Outlook
3.3 Mapping Application Penetration and Growth Outlook, 2020
3.4 Impact of COVID-19
3.5 Market dynamics
3.5.1 Market Drivers Analysis
18.104.22.168 Refocus on personalized medicine and genetic testing
22.214.171.124 Automation of biobanks
126.96.36.199 Increased incidence of cancer and other chronic disorders
3.5.2 Analysis of market constraints
188.8.131.52 Ethical and legal issues relating to banking services
3.5.3 Analysis of market challenges
184.108.40.206 Challenges related to DNA banks
3.5.4 Market Opportunity Analysis
220.127.116.11 Financing and investments in the field of DNA and RNA banking
3.6 Analysis of the business environment
3.6.1 SWOT analysis; By factor (Political & Legal, Economic and Technological)
3.6.2 Porter’s five forces analysis
Chapter 4 Business Analysis of Service Type of DNA and RNA Banking Services Market
4.1 DNA and RNA banking services market: analysis of service type movements
4.2 Transport service
4.3 Processing service
4.4 Storage service
4.5 Quality control service
4.6 Data storage
Chapter 5 Business Analysis of DNA and RNA Banking Services Market Sample Type
5.1 DNA and RNA Banking Services Market: Analysis of Sample Type Movements
5.3 Oral (saliva) and hair follicle swabs
Chapter 6 Business Analysis of DNA and RNA Banking Market Applications
6.1 DNA and RNA Banking Services Market: Application Movement Analysis
6.3 Drug discovery and clinical research
6.4 Clinical diagnosis
Chapter 7 Business Analysis of DNA and RNA Banking Market End Use
7.1 DNA and RNA Banking Services Market: Analysis of End-Use Movements
7.2 Academic research
7.3 Pharmaceutical and biotechnology companies
7.4 Hospitals and diagnostic centers
Chapter 8 Regional Business Analysis of DNA and RNA Banking Services Market
8.1 DNA and RNA banking services market: analysis of regional movements, 2020 and 2027
Chapter 9 Company Profiles of DNA and RNA Banking Services Market
Thermo Fisher Scientific, Inc.
OraSure Technologies, Inc.
US Biolab Corporation, Inc.
Infinity Biologix LLP
Brooks Life Sciences
For more information on this report, visit https://www.researchandmarkets.com/r/cmox42
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900